EORTC - European Organisation for Research and Treatment of Cancer

EORTC - European Organisation for Research and Treatment of Cancer is a non-governmental, non-profit organization established in 1962 that aims to advance cancer therapy. The organization brings together clinical cancer research experts across Europe to develop improved treatments for cancer patients, ultimately striving to extend survival and enhance quality of life. EORTC engages in a wide range of activities, from translational research to large, prospective, multi-center, phase III clinical trials focusing on evaluating novel therapies, treatment strategies, and patient quality of life. Headquartered in Brussels, Belgium, EORTC operates as a unique international clinical research infrastructure.

With a primary focus on the biotechnology and healthcare industries, EORTC's mission aligns with the critical need to address the challenges of cancer treatment and research advancements. As a venture capital firm, investing in EORTC presents an opportunity to contribute to the crucial field of oncology while potentially gaining from the organization's pursuit of innovative cancer treatments. While specific details regarding the last investment and investors are not available at this time, the impact of supporting such a pivotal entity in the fight against cancer could be a meaningful endeavor for venture capitalists seeking both social impact and potential financial returns.

For additional information about EORTC and its work in the field of cancer research and treatment, please visit the organization's website at www.eortc.org.